All In Biotech

Drug Trial Radar · NCT06197568

Proof of Concept Study of Vaginal AZU-101 in Vulvovaginal Atrophy in Postmenopausal Women

A Double-blind, Randomized, Placebo-controlled Proof oF Concept Clinical Study to Evaluate the Safety, Pharmacokinetics, AND Pharmacodynamics of Vaginal AZU-101 (Lasofoxifene Tartrate) in Postmenopausal Women

Last checked: Nov 19, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

90

Planned (sponsor's estimate)

Start

Jul 1, 2026

Primary completion

Dec 31, 2026

Study completion Jun 30, 2027

Sponsor

Lead sponsor
Azure Biotech Inc.Industry
Sponsor type
Industry
Collaborators
Nucleus Network Ltd
First posted
Jan 9, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 45 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Study Objectives: Primary: • To assess the safety, tolerability, and systemic pharmacokinetics (PK) of AZU-101 Secondary: • To evaluate efficacy of daily vaginal doses of AZU-101 in postmenopausal women on vaginal epithelium

Conditions

  • Vulvo Vaginal Atrophy (VVA)

Interventions

  • Lasofoxifene TartrateDrug

    1.0 ug for 14 daily doses

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants Who Had Any Serious Adverse Events or Any Treatment Emergent Adverse Events With Severity Greater Than "Moderate" as measured by CTCAE v4.0Time frame: 15 days
  2. Pharmacokinetics (AUC0-∞)Time frame: 24 hours after day 1 and day 14
  3. Pharmacokinetics (Tmax)Time frame: 24 hours after day 1 and day 14
  4. Pharmacokinetics (Cmax)Time frame: 24 hours after day 1 and day 14

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Nucleus Network

    Saint Paul, Minnesota · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.